Service d'immunologie et d'allergie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


1838 publications

En préparation
Uniting Machine Intelligence, Brain and Behavioural Sciences to Assist Criminal Justice.
Chén Oliver Y.
[URN][serval:BIB_D2B7729FCF9B]
 
Distinct immune signatures are a potent tool in the clinical management of cytokine-related syndrome during immune checkpoint therapy
Daoudlarian Douglas, Segot Amandine, Latifyan Sofiya, Bartolini Robin, Joo Victor, Mederos Nuria, Bouchaab Hasna, Demicheli Rita, Abdelhamid Karim, Ferahta Nabila et al..
[DOI][serval:BIB_818D0F24F67B]
Enhancing Uncertain Demand Prediction in Hospitals Using Simple and Advanced Machine Learning
Hu Annie, Stockman Samuel, Wu Xun, Wood Richard, Zhi Bangdong, Chén Oliver Yibing.
[URN][DOI][serval:BIB_41415B955943]
 
RAIN: a Machine Learning-based identification for HIV-1 bNAbs
Perez Laurent, Foglierini Mathilde.
[DOI][Pmid][serval:BIB_BC17BC4AD414]
 
Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Petit Pierre-Florent, Daoudlarian Douglas, Latifyan Sofiya, Bouchaab Hasna, Mederos Nuria, Doms Jacqueline, Abdelhamid Karim, Ferahta Nabila, Mencarelli Lucrezia, Joo Victor et al..
[DOI][serval:BIB_34BED0C92D50]
 
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity
Power John R, Dolladille Charles, Procureur Adriel, Ederhy Stephane R, Palaskas Nicolas L, Lehmann Lorenz H, Cautela Jennifer, Courand Pierre-Yves, Hayek Salim S, Zhu Han et al..
[DOI][Pmid][serval:BIB_67AC9C14F205]
Sous presse
 
Tolerance of penicillin V in patients with confirmed delayed hypersensitivity reactions to aminopenicillins.
ALOtaibi I., Khoudja R.Y., Isabwe GAC, Fein M., Stehlin F., James F., Ben-Shoshan M., Trubiano J.A., Copaescu A.M. The journal of allergy and clinical immunology. In practice. Peer-reviewed.
[DOI][Pmid][serval:BIB_C98AC35E406E]
 
Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsis.
Baillie J.K., Angus D., Burnham K., Calandra T., Calfee C., Gutteridge A., Hacohen N., Khatri P., Langley R., Ma'ayan A. et al. Intensive care medicine. Peer-reviewed.
[DOI][Pmid][serval:BIB_4F5BE1B7235E]
 
Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2.
Blanchard G., Atallah I., Blanchard M., Fehrenbacher B., Schaller M., Riccio O., Ballerini C., Candotti F., Guenova E. The British journal of dermatology. Peer-reviewed.
[DOI][Pmid][serval:BIB_FCE7997FD1E1]
 
HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin Lymphoma.
Chantziou A., Brenna C., Ioannidou K., Chen O.Y., Korkolopoulou P.A., Antoniadou A., Psichogiou M., Papaioannou M., Tsirigotis P., Foukas P.G. et al. Blood advances. Peer-reviewed.
[DOI][Pmid][serval:BIB_D343689440C2]
 
Simultaneous combined transplantation: Intricacies in immunosuppression management.
Del Bello A., Vionnet J., Congy-Jolivet N., Kamar N. Transplantation reviews. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ADE0D933916F]
 
Rebalancing the Immune System to Treat Type 1 Diabetes.
Muller Y.D., Ho P., Bluestone J.A., Tang Q. Cold Spring Harbor perspectives in medicine. Peer-reviewed.
[DOI][Pmid][serval:BIB_E72BFAABAA42]
 
The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.
Novysedlak R., Guney M., Al Khouri M., Bartolini R., Koumbas Foley L., Benesova I., Ozaniak A., Novak V., Vesely S., Pacas P. et al. Oncology. Peer-reviewed.
[DOI][Pmid][serval:BIB_F33B7BC8896A]
2024
 
COVID-19 vaccine confidence and its effect on vaccine uptake among people with hypertension or diabetes mellitus in Kilimanjaro region, Tanzania.
Mtei M., Mwasamila B D., Amour C., Bilakwate J.S., Shirima L.J., Farah A., Mboya I.B., Ngocho J., George J.M., Msuya S.E., 2024/12/31. Human vaccines & immunotherapeutics, 20 (1) p. 2396213. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D511D6B193AC]
 
Extrafollicular CD19<sup>low</sup>CXCR5<sup>-</sup>CD11c<sup>-</sup> double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosus.
Chizzolini C., Guery J.C., Noulet F., Gruaz L., Cenac C., Frasca L., Spoerl D., Arlettaz L., Horisberger A., Ribi C. et al., 2024/12. Journal of translational autoimmunity, 9 p. 100252. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4B7724F967B]
The characterization of CD8+ T-cell responses in COVID-19.
Yang Y., Miller H., Byazrova M.G., Cndotti F., Benlagha K., Camara NOS, Shi J., Forsman H., Lee P., Yang L. et al., 2024/12. Emerging microbes & infections, 13 (1) p. 2287118. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C213415EB1A6]
 
Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.
Shatila M., Zhang H.C., Shirwaikar Thomas A., Machado A.P., Naz S., Mittal N., Catinis C., Varatharajalu K., Colli Cruz C., Lu E. et al., 2024/11/14. Journal for immunotherapy of cancer, 12 (11). Peer-reviewed.
[DOI][Pmid][serval:BIB_ECA4EEE5A337]
Socioeconomic status across the early life course predicts gene expression signatures of disease and senescence.
Potente C., Bodelet J., Himeri H., Cole S., Harris K., Shanahan M., 2024/11/11. Journal of epidemiology and community health, 78 (12) pp. 752-758. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E61139497F8A]
Variants in IGLL1 cause a broad phenotype from agammaglobulinemia to transient hypogammaglobulinemia.
Soomann M., Bily V., Elgizouli M., Kraemer D., Akgül G., von Bernuth H., Bloomfield M., Brodszki N., Candotti F., Förster-Waldl E. et al., 2024/11. The Journal of allergy and clinical immunology, 154 (5) pp. 1313-1324.e7. Peer-reviewed.
[DOI][Pmid][serval:BIB_FC5AAA31445F]
Skin testing and challenge in patients with immediate hypersensitivity reactions to gadolinium-based contrast agents identify safe future options.
Stehlin F., Khoudja R.Y., Lee D., Toupin J.F., Isabwe GAC, Fein M., Al-Otaibi I., Phillips E.J., Trubiano J.A., Copaescu A.M., 2024/10. Allergology international, 73 (4) pp. 610-614. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A494750F740C]
 
Entéropathie induite par les sartans [Sartan-induced enteropathy]
Chabenet F., Ribi C., Nozic A., 2024/09/18. Revue medicale suisse, 20 (887) pp. 1665-1668. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0D7D80A58C4F]
 
Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study.
Petit P.F., Daoudlarian D., Latifyan S., Bouchaab H., Mederos N., Doms J., Abdelhamid K., Ferahta N., Mencarelli L., Joo V. et al., 2024/09/04. Annals of oncology. Peer-reviewed.
[DOI][Pmid][serval:BIB_0BA6393BFB37]
 
Development of novel broad-range pan-genus PCR assays for the detection of Tropheryma species.
Tagini F., Belkoniene M., Jaton K., Opota O., Greub G., 2024/09. Journal of medical microbiology, 73 (9). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6ABCC5D8FB1]
 
Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study.
Abela I.A., Hauser A., Schwarzmüller M., Pasin C., Kusejko K., Epp S., Cavassini M., Battegay M., Rauch A., Calmy A. et al., 2024/08/16. The Journal of infectious diseases, 230 (2) pp. e292-e304. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F53FC91CC440]
Follicular Immune Landscaping Reveals a Distinct Profile of FOXP3<sup>hi</sup>CD4<sup>hi</sup> T Cells in Treated Compared to Untreated HIV.
Georgakis S., Orfanakis M., Brenna C., Burgermeister S., Del Rio Estrada P.M., González-Navarro M., Torres-Ruiz F., Reyes-Terán G., Avila-Rios S., Luna-Villalobos Y.A. et al., 2024/08/12. Vaccines, 12 (8). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F34C11CEE24]
 
Immunoglobulin class-switch recombination: Mechanism, regulation, and related diseases.
Liu J.C., Zhang K., Zhang X., Guan F., Zeng H., Kubo M., Lee P., Candotti F., James L.K., Camara NOS et al., 2024/08. MedComm, 5 (8) pp. e662. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BDDD0EE7D2F4]
Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
Audran R., Karoui O., Donnet L., Soumas V., Fares F., Lovis A., Noirez L., Cavassini M., Fayet-Mello A., Satti I. et al., 2024/08. The Journal of infection, 89 (2) p. 106205. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_01B38E4B14CC]
 
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial.
Garrett N., Dintwe O., Monaco C.L., Jones M., Seaton K.E., Church E.C., Grunenberg N., Hutter J., deCamp A., Huang Y. et al., 2024/08/01. Journal of acquired immune deficiency syndromes, 96 (4) pp. 350-360. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D713D414CFEE]
 
Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screen.
Neuner-Jehle N., Zeeb M., Thorball C.W., Fellay J., Metzner K.J., Frischknecht P., Neumann K., Leeman C., Rauch A., Stöckle M. et al., 2024/08. PLoS pathogens, 20 (8) pp. e1012385. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A3A54E74EB11]
By suppressing its MD-PhD fellowship programme, the Swiss National Science Foundation reduces the attractiveness of the physician-scientist career path.
Lyon A., Porret R., Ferrari T., 2024/07/04. Swiss medical weekly, 154 p. 3605. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_06F6C75FFA13]
 
Immunological and Haematological Relevance of Helminths and Mycobacterium tuberculosis Complex Coinfection among Newly Diagnosed Pulmonary Tuberculosis Patients from Bobo-Dioulasso, Burkina Faso.
Djibougou D.A., Mensah G.I., Kaboré A., Toé I., Sawadogo L.T., Lompo P.F., Kone AMM, Hien H., Meda C.Z., Combary A. et al., 2024/07/03. Biomedicines, 12 (7). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5550B74C99B3]
 
Is HIV epidemic control by 2030 realistic?
Beyrer C., Tomaras G.D., Gelderblom H.C., Gray G.E., Janes H.E., Bekker L.G., Millett G., Pantaleo G., Buchbinder S., Corey L., 2024/07. The lancet. HIV, 11 (7) pp. e489-e494. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7A1AFFD30706]
 
The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C.
Caorsi R., Consolaro A., Speziani C., Sozeri B., Ulu K., Faugier-Fuentes E., Menchaca-Aguayo H., Ozen S., Sener S., Akhter Rahman S. et al., 2024/07. Journal of autoimmunity, 147 p. 103265. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_25A4B1A13301]
RAIN: machine learning-based identification for HIV-1 bNAbs.
Foglierini M., Nortier P., Schelling R., Winiger R.R., Jacquet P., O'Dell S., Demurtas D., Mpina M., Lweno O., Muller Y.D. et al., 2024/06/24. Nature communications, 15 (1) p. 5339. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7E0011402784]
 
Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.
Audran R., Chtioui H., Thierry A.C., Mayor C.E., Vallotton L., Dao K., Rothuizen L.E., Maghraoui A., Pennella E.J., Brunner-Ferber F. et al., 2024/06/04. Scientific reports, 14 (1) p. 12872. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_728141A25F81]
 
Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.
Halfon M., Tankeu A.T., Ribi C., 2024/06/03. International journal of molecular sciences, 25 (11). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53E45C4DF309]
 
Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.
Karbiener M., Kindle G., Meyts I., Seppänen MRJ, Candotti F., Kamieniak M., Ilk R., Kreil T.R., Seidel M.G., ESID-COVID Consortium, 2024/06. Journal of medical virology, 96 (6) pp. e29738. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3EE478B889BC]
 
Deep mapping of the cytokine release syndrome inflammatory continuum: Comprehensive grade-specific profiling and differentiation from sepsis in patients receiving immune checkpoint therapy.
Obeid Michel, Daoudlarian Douglas, Segot Amandine, Latifyan Sofiya, Bouchaab Hasna, Mederos Nuria, Abdelhamid Karim, Ferahta Nabila, Stravodimou Athina, Shabafrouz Keyvan et al., 2024/06/01. Journal of Clinical Oncology, 42 (16_suppl) pp. 12129-12129.
[DOI][serval:BIB_928272EB14D0]
 
High-dimensional longitudinal immune profiling uncovers a dual role of the CXCL9/CXCR3, CXCL13/CXCR5, and CCL11/CCL3 axis in the coupling of immune-related adverse events to immune checkpoint inhibitor response.
Obeid Michel, Joo Victor, Daoudlarian Douglas, Bartolini Robin, Bouchaab Hasna, Latifyan Sofiya, Mederos Nuria, Abdelhamid Karim, Mosimann Valérie, Ferahta Nabila et al., 2024/06/01. Journal of Clinical Oncology, 42 (16_suppl) pp. 2512-2512.
[DOI][serval:BIB_DDD63EA0571E]
 
Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.
Walsh S.R., Gay C.L., Karuna S.T., Hyrien O., Skalland T., Mayer K.H., Sobieszczyk M.E., Baden L.R., Goepfert P.A., Del Rio C. et al., 2024/06. PLoS medicine, 21 (6) pp. e1004329. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5633EE3B4E64]
 
Towards personalized medicine: a scoping review of immunotherapy in sepsis.
Slim M.A., van Mourik N., Bakkerus L., Fuller K., Acharya L., Giannidis T., Dionne J.C., Oczkowski SJW, Netea M.G., Pickkers P. et al., 2024/05/28. Critical care, 28 (1) p. 183. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C6BCD297355]
Non-uptake of COVID-19 vaccines and reasons for non-uptake among healthcare workers in Uganda: a cross-sectional study.
Kyakuwa N., Abaasa A., Mpooya S., Kalutte H., Atuhairwe C., Perez L., Kikaire B., 2024/05/25. BMC health services research, 24 (1) p. 663. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB33FBD0677F]
 
Editorial introduction
Debyser Zeger, Perreau Matthieu, Kaufmann Daniel, 2024/05. Current Opinion in HIV and AIDS, 19 (3) pp. v-vi.
[DOI][WoS][Pmid][serval:BIB_99A4353F3026]
Pilot Study of sC5b-9 and Bb Fragment Plasma Levels in Crescentic Immunoglobulin A Nephropathy.
Guzzo G., Sadallah S., Rousson V., Herrera-Gómez F., Pantaleo G., Pascual M., Teta D., 2024/05. Kidney international reports, 9 (5) pp. 1517-1520. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E09E9C8D368F]
 
Strategies to target the central nervous system HIV reservoir.
Mastrangelo A., Gama L., Cinque P., 2024/05/01. Current opinion in HIV and AIDS, 19 (3) pp. 133-140. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BAE3F1895BB]
The multifaceted nature of HIV tissue reservoirs.
Banga R., Perreau M., 2024/05/01. Current opinion in HIV and AIDS, 19 (3) pp. 116-123. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_41BEE245D401]
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma.
Joo V., Abdelhamid K., Noto A., Latifyan S., Martina F., Daoudlarian D., De Micheli R., Pruijm M., Peters S., Hullin R. et al., 2024/04/30. Nature communications, 15 (1) p. 3664. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4D3A2A46F635]
 
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with sera from Plasmodium falciparum endemic areas of Africa.
Balam S., Miura K., Ayadi I., Konaté D., Incandela N.C., Agnolon V., Guindo M.A., Diakité SAS, Olugbile S., Nebie I. et al., 2024/04/15..
[DOI][Pmid][serval:BIB_83156CECA762]
 
Vaccine Efficacy, Impact, Hesitancy, and Acceptance: Trends for Public Health.
Said E.A., Noto A., Cardinaud S., Al-Jabri A.A., 2024/04/11. Vaccines, 12 (4). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B3714DFC039F]
 
Comprendre les réactions d’hypersensibilité aux anticorps monoclonaux [Understanding hypersensitivity reactions to monoclonal antibodies]
Cattaneo V., Belkoniene M., Porret R., Harr T., Muller Y.D., 2024/04/03. Revue medicale suisse, 20 (868) pp. 705-710. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0EAD4399A1BF]
 
Fake news en médecine et leur impact sur nos patients. L’exemple de l’hydroxychloroquine.
Ribi C., 2024/04/03. Revue medicale suisse, 20 (868) pp. 679-680. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FD40C04EE551]
 
La connectivite mixte et sa prise en charge [Mixed connective tissue disease and its management]
Curraj E., Belkoniene M., Keutchakeu-Tchatcho C., Ringwald M., Ribi C., 2024/04/03. Revue medicale suisse, 20 (868) pp. 699-704. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F3EAB7D18540]
 
Sarcoïdose cardiaque : un défi diagnostique et thérapeutique [Cardiac sarcoidosis: a diagnostic and therapeutic challenge]
Ammann S., Dominati A., Meyer P., Pruvot E., Ribi C., Seebach J., 2024/04/03. Revue medicale suisse, 20 (868) pp. 682-687. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EFA8F7C80D0B]
 
Thérapie cellulaire CAR-T dans le traitement des maladies auto-immunes [CAR-T therapy for autoimmune diseases]
Alcaraz-Serna A., Porret R., Trueb L., Ribi C., Seebach J., Muller Y.D., 2024/04/03. Revue medicale suisse, 20 (868) pp. 688-693. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FC7F901BBC55]
Die Bedeutung des QuantiFERON Gold Plus-Tests für die Diagnose der vermuteten Augentuberkulose [The Importance of QuantiFERON Gold Plus Test for the Diagnosis of Presumed Ocular Tuberculosis]
Bruzzone F., Plebani M., Koryllou A., Perreau M., Guex-Crosier Y., 2024/04. Klinische Monatsblatter fur Augenheilkunde, 241 (4) pp. 432-434. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E61763DE6E63]
Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma.
Borcinova M., Bartolini R., Foley L.K., Novak V., Taborska P., Stakheev D., Rataj M., Smrz D., Fialova M., Hacek J. et al., 2024/04. Translational oncology, 42 p. 101891. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B55655674776]
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.
Vicino A., Hottinger A.F., Latifyan S., Boughdad S., Becce F., Prior J.O., Kuntzer T., Brouland J.P., Dunet V., Obeid M. et al., 2024/04. Journal of neurology, 271 (4) pp. 1947-1958. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_29F8761FAE12]
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
Bassetti M., Giacobbe D.R., Agvald-Ohman C., Akova M., Alastruey-Izquierdo A., Arikan-Akdagli S., Azoulay E., Blot S., Cornely O.A., Cuenca-Estrella M. et al., 2024/04. Intensive care medicine, 50 (4) pp. 502-515. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F8D4AD6C304]
 
Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies.
Shankar-Hari M., Calandra T., Soares M.P., Bauer M., Wiersinga W.J., Prescott H.C., Knight J.C., Baillie K.J., Bos LDJ, Derde LPG et al., 2024/04. The Lancet. Respiratory medicine, 12 (4) pp. 323-336. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_774F5F5B62A7]
Residual Partial Least Squares Learning: Brain Cortical Thickness Simultaneously Predicts Eight Non-pairwise-correlated Behavioural and Disease Outcomes in Alzheimer's Disease.
Chén O.Y., Vũ D.T., Diaz C.S., Bodelet J.S., Phan H., Allali G., Nguyen V.D., Cao H., He X., Müller Y. et al., 2024/03/27..
[URN][DOI][Pmid][serval:BIB_3B332933DA5C]
Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis.
Gillard J., Suffiotti M., Brazda P., Venkatasubramanian P.B., Versteegen P., de Jonge M.I., Kelly D., Bibi S., Pinto M.V., Simonetti E. et al., 2024/03/08. Nature communications, 15 (1) p. 2133. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C91442BE52F4]
 
Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia.
Mastrangelo A., Scotti G.M., Manteiga J.G., Gisslén M., Price R.W., Bestetti A., Turrini F., Caccia R., Gorelik L., Morelli M.J. et al., 2024/03/01. AIDS, 38 (3) pp. 299-308. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E10D6B785AB6]
 
Therapeutic antibodies and alternative formats against SARS-CoV-2.
Winiger R.R., Perez L., 2024/03. Antiviral research, 223 p. 105820. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A112961BCF9C]
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.
Gasca-Capote C., Lian X., Gao C., Roseto I.C., Jiménez-León M.R., Gladkov G., Camacho-Sojo M.I., Pérez-Gómez A., Gallego I., Lopez-Cortes L.E. et al., 2024/02/20. The Journal of clinical investigation, 134 (8). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B3A795F338D3]
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O., Laager M., Hirzel C., Neofytos D., Walti L.N., Hoenger G., Binet I., Schnyder A., Stampf S., Koller M. et al., 2024/02/17. Clinical infectious diseases, 78 (2) pp. 312-323. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA450EA2BB8A]
Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients.
Schrijver I.T., Herderschee J., Théroude C., Kritikos A., Leijte G., Le Roy D., Brochut M., Chiche J.D., Perreau M., Pantaleo G. et al., 2024/02/08. Cells, 13 (4). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AAE7B79746C8]
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort.
Windirsch K., Jordan S., Becker M.O., Bruni C., Dobrota R., Elhai M., Garaiman I.A., Mihai C.M., Iudici M., Hasler P. et al., 2024/02/06. Swiss medical weekly, 154 p. 3630. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A434393F87C4]
A Bayesian functional approach to test models of life course epidemiology over continuous time.
Bodelet J., Potente C., Blanc G., Chumbley J., Imeri H., Hofer S., Harris K.M., Muniz-Terrera G., Shanahan M., 2024/02/01. International journal of epidemiology, 53 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_57BB1671B649]
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database.
Lepri G., Bruni C., Tofani L., Moggi-Pignone A., Orlandi M., Tomassetti S., Hughes M., Del Galdo F., Irace R., Distler O. et al., 2024/01/30. Diagnostics, 14 (3). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C74266759675]
 
Immunologie: ce qui a changé en 2023 [Immunology: what's new in 2023]
Ringwald M., Ribi C., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 47-50. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_DF897A402A27]
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies.
Moullan N., Asiago J., Stecco K., Hadi S., Albizem M., Tieu H., Hock B., Fenwick C., Lin K., Lengsfeld T. et al., 2024/01. Infectious diseases and therapy, 13 (1) pp. 173-187. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_890F055350A3]
 
COVID-19 booster vaccine acceptance following allergy evaluation in individuals with allergies.
Stehlin F., Khoudja R.Y., Al-Otaibi I., ALMuhizi F., Fein M., Gilbert L., Tsoukas C., Ben-Shoshan M., Copaescu A.M., Isabwe GAC, 2024/01. The journal of allergy and clinical immunology. In practice, 12 (1) pp. 242-245.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F559B85F5530]
 
Cryoglobulinemic vasculitis triggered by Staphylococcus aureus endocarditis with chronic hepatitis C virus co-infection: a case report and literature review.
Reinberg C., Vingerhoets S., Pavlova O., Guenova E., Papadimitriou-Olivgeris M., Comte D., 2024. Frontiers in immunology, 15 p. 1385086. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0B6B4366346E]
 
Editorial introductions
Pantaleo Giuseppe, Deeks Steven G., Alba Diana, 2024/01. Current Opinion in HIV and AIDS, 19 (1) pp. V-VI.
[DOI][WoS][serval:BIB_4BCD8844162A]
 
Editorial: Understanding convergent evasion mechanisms in cancer and chronic infection: implications for immunotherapy.
Echchannaoui H., Perreau M., Schild H., Theobald M., 2024. Frontiers in immunology, 15 p. 1450555. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_64FD482C89E2]
 
Extending Multiple Testing with Unknown Test Dependency via the CoCo Test: With Applications to Cancer Studies.
Gou Jiangtao, Wu Kai, Chén Oliver Y, 2024..
[serval:BIB_9F35DD74CF00]
 
Factor H-related protein 1 in systemic lupus erythematosus.
Kleer J.S., Klehr J., Dubler D., Infanti L., Chizzolini C., Huynh-Do U., Ribi C., Trendelenburg M., 2024. Frontiers in immunology, 15 p. 1447991. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FA2DEBC01BDE]
High uptake of COVID-19 vaccines among healthcare workers in urban Uganda.
Kyakuwa N., Kimbugwe G., Nakanjako F., Kalute H., Mpooya S., Atuhairwe C., Perez L., Kikaire B., 2024. PloS one, 19 (4) pp. e0277072. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F48C46C29EC1]
Mental health and burnout during medical school: Longitudinal evolution and covariates.
Carrard V., Berney S., Bourquin C., Ranjbar S., Castelao E., Schlegel K., Gaume J., Bart P.A., Schmid Mast M., Preisig M. et al., 2024. PloS one, 19 (4) pp. e0295100. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EE638253A8B9]
Pre-transplant donor specific antibodies in ABO incompatible kidney transplantation - data from the Swiss transplant cohort study.
Deng Y., Frischnknecht L., Wehmeier C., de Rougemont O., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2024. Frontiers in immunology, 15 p. 1355128. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DF8B8B7ED9A9]
Residual Partial Least Squares Learning: Brain Cortical Thickness Simultaneously Predicts Eight Non-pairwise-correlated Behavioural and Disease Outcomes in Alzheimer’s Disease
Chén Oliver Y, Vu Duy Thanh, Diaz Christelle Schneuwly, Bodelet Julien, Phan Huy, Allali Gilles, Nguyen Viet-Dung, Cao Hengyi, He Xingru, Muller Yannick et al., 2024..
[URN][DOI][serval:BIB_DE5854C92A82]
Risk factors for allergy documentation in electronic health record: A retrospective study in a tertiary health center in Switzerland.
Ringwald M., Moi L., Wetzel A., Comte D., Muller Y.D., Ribi C., 2024/01. Allergology international, 73 (1) pp. 143-150. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_931C991F3DB5]
 
Self-reported neurocognitive complaints in the Swiss HIV Cohort Study: a viral genome-wide association study.
Zeeb M., Pasin C., Cavassini M., Bieler-Aeschlimann M., Frischknecht P., Kusejko K., Fellay J., Blanquart F., Metzner K.J., Neumann K. et al., 2024. Brain communications, 6 (4) pp. fcae188. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F4D8C677D8C6]
 
SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responses.
Mosmann T.R., Rebhahn J.A., De Rosa S.C., Keefer M.C., McElrath M.J., Rouphael N.G., Pantaleo G., Gilbert P.B., Corey L., Kobie J.J. et al., 2024. Frontiers in immunology, 15 p. 1347926. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E90934C264D]
 
The pathophysiology of sepsis and precision-medicine-based immunotherapy.
Giamarellos-Bourboulis E.J., Aschenbrenner A.C., Bauer M., Bock C., Calandra T., Gat-Viks I., Kyriazopoulou E., Lupse M., Monneret G., Pickkers P. et al., 2024/01. Nature immunology, 25 (1) pp. 19-28. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_06061B0B11B8]
Uptake of human papilloma virus vaccination among adolescent girls living with HIV in Uganda: A mixed methods study.
Nakibuuka V., Muddu M., Kraehenbuhl J.P., Birungi C., Semitala F.C., Tusubira A.K., 2024. PloS one, 19 (8) pp. e0300155. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_94D71FC2B490]
2023
Statistical Quantile Learning for Large, Nonlinear, and Additive Latent Variable Models.
Bodelet Julien, Blanc Guillaume, Shan Jiajun, Terrera Graciela M., Chén Oliver Y, 2023/12/29..
[URN][DOI][serval:BIB_0622E4AB21A0]
Development of hybrid immunity during a period of high incidence of Omicron infections.
Frei A., Kaufmann M., Amati R., Butty Dettwiler A., von Wyl V., Annoni A.M., Vincentini J., Pellaton C., Pantaleo G., Fehr J.S. et al., 2023/12/25. International journal of epidemiology, 52 (6) pp. 1696-1707. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_58F5CD0974E9]
The Roles, Challenges, and Merits of the p Value.
Chén Oliver Y, Bodelet Julien S, Saraiva Raúl G, Phan Huy, Di Junrui, Nagels Guy, Schwantje Tom, Cao Hengyi, Gou Jiangtao, Reinen Jenna M et al., 2023/12/08. Patterns, 4 (12) p. 100878. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D084688E0A6D]
 
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.
Bettiol A., Urban M.L., Padoan R., Groh M., Lopalco G., Egan A., Cottin V., Fraticelli P., Crimi C., Del Giacco S. et al., 2023/12. The Lancet. Rheumatology, 5 (12) pp. e707-e715. Peer-reviewed.
[DOI][Pmid][serval:BIB_24C3A2CB1959]
 
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys.
Fenwick C., Turelli P., Duhoo Y., Lau K., Herate C., Marlin R., Lamrayah M., Campos J., Esteves-Leuenberger L., Farina A. et al., 2023/12. The Journal of infection, 87 (6) pp. 524-537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A69FF2015C1]
The role of dendritic cells in COVID-19 infection.
Wang X., Guan F., Miller H., Byazrova M.G., Cndotti F., Benlagha K., Camara NOS, Lei J., Filatov A., Liu C., 2023/12. Emerging microbes & infections, 12 (1) p. 2195019. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9405D2DA3A70]
 
Immunosuppresseurs et antécédent de cancer : quel risque de récidive?
Comte D., 2023/11/29. Revue medicale suisse, 19 (852) p. 2271. Peer-reviewed.
[URN][Pmid][serval:BIB_631A1993D9EF]
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study.
Raineri A., Radtke T., Rueegg S., Haile S.R., Menges D., Ballouz T., Ulyte A., Fehr J., Cornejo D.L., Pantaleo G. et al., 2023/11/27. Nature communications, 14 (1) p. 7764. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_BDC2C0B508CE]
Polyarteritis Nodosa: Old Disease, New Etiologies.
Wolff L., Horisberger A., Moi L., Karampetsou M.P., Comte D., 2023/11/23. International journal of molecular sciences, 24 (23). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BEEF8077D35B]
Human secondary lymphoid organ immune landscaping revealed by multiplex imaging analysis
Orfanakis Michail, Georgakis Spiros, Brenna Cloé, Fenwick Craig, Pantaleo Giuseppe, Chén Oliver Y., Konstantinos Petrovas (eds.), 2023/11..
[URN][serval:BIB_935D3963D92A]
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
Ambrosioni J., Levi L., Alagaratnam J., Van Bremen K., Mastrangelo A., Waalewijn H., Molina J.M., Guaraldi G., Winston A., Boesecke C. et al., 2023/11. HIV medicine, 24 (11) pp. 1126-1136. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C3981328BD1]
Novel targets for immune-checkpoint inhibition in cancer.
Borgeaud M., Sandoval J., Obeid M., Banna G., Michielin O., Addeo A., Friedlaender A., 2023/11. Cancer treatment reviews, 120 p. 102614. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FED5F30A54BE]
Worse cardiovascular and renal outcome in male SLE patients.
Mihailovic J., Ribi C., Chizzolini C., Trendelenburg M., Von Kempis J., Dahdal S., Huynh-Do U., Swiss Systemic Lupus Erythematosus Cohort Study Group (SSCS), 2023/10/30. Scientific reports, 13 (1) p. 18628. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6E0F97DEE154]
Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART.
Banga R., Procopio F.A., Lana E., Gladkov G.T., Roseto I., Parsons E.M., Lian X., Armani-Tourret M., Bellefroid M., Gao C. et al., 2023/10/11. Cell host & microbe, 31 (10) pp. 1714-1731.e9. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9F739E97B9B6]
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses.
Ols S., Lenart K., Arcoverde Cerveira R., Miranda M.C., Brunette N., Kochmann J., Corcoran M., Skotheim R., Philomin A., Cagigi A. et al., 2023/10/10. Immunity, 56 (10) pp. 2425-2441.e14. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8E02FAD2D2CE]
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines.
Alcaraz-Serna A., Noto A., Ermellino L., Monzambani-Banderet V., Tommasini F., Stehlin F., Girard C., Perreau M., Muller Y.D., 2023/10. Allergology international, 72 (4) pp. 600-603. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_58939F65DB86]
Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome.
Arlabosse T., Materna M., Riccio O., Schnider C., Angelini F., Perreau M., Rochat I., Superti-Furga A., Campos-Xavier B., Héritier S. et al., 2023/10. Journal of clinical immunology, 43 (7) p. 1674. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D920DAB3A125]
 
L-SeqSleepNet: Whole-cycle Long Sequence Modeling for Automatic Sleep Staging.
Phan H., Lorenzen K.P., Heremans E., Chén Oliver Y, Tran M.C., Koch P., Mertins A., Baumert M., Mikkelsen K.B., de Vos M., 2023/10. IEEE journal of biomedical and health informatics, 27 (10) pp. 4748-4757. Peer-reviewed.
[DOI][Pmid][serval:BIB_9BE4A24B8351]
New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.
Arlabosse T., Materna M., Riccio O., Schnider C., Angelini F., Perreau M., Rochat I., Superti-Furga A., Campos-Xavier B., Héritier S. et al., 2023/10. Journal of clinical immunology, 43 (7) pp. 1566-1580. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BB16C2AE927C]
 
80 C5b-9 and Bb factor levels as potential novel biomarkers in crescentic IgA nephropathy
Guzzo Gabriella, Sadallah Salima, Pantaleo Giuseppe, Pascual Manuel, Teta Daniel, 2023/09., XXIX (29th) International Complement Workshop 2023 p. 152531 dans Immunobiology.
[DOI][WoS][serval:BIB_5C66C94BEBD0]
 
Myositis manifesting as respiratory insufficiency with anti-RNA polymerase III antibodies: an unusual presentation of graft-versus-host disease.
Wolff L., Clottu A., Mamez A.C., Ribi C., Grandoni F., 2023/09. Leukemia & lymphoma, 64 (9) pp. 1588-1591. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D11BC441C65]
 
Pediatric Allergy and Immunology (PAI) is for polishing with artificial intelligence, but careful use.
Eigenmann P., Akenroye A., Atanaskovic Markovic M., Candotti F., Ebisawa M., Genuneit J., Kalayci Ö., Kollmann D., Leung ASY, Peters R.L. et al., 2023/09. Pediatric allergy and immunology, 34 (9) pp. e14023. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F053F1C1ECE1]
HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfection.
Obuku A.E., Lugemwa J.K., Abaasa A., Joloba M., Ding S., Pollara J., Ferrari G., Harari A., Pantaleo G., Kaleebu P., 2023/08/29. BMC immunology, 24 (1) p. 25. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62C12F4E0858]
 
Relentless bilateral occlusive vasculitis in a patient with Crohn's disease treated with adalimumab after immunization with mRNA SARS-CoV-2 vaccine: a case report
Bughin Alice, Casanova Alex, Ribi Camillo, Guex-Crosier Yan, 2023/08/25..
[DOI][serval:BIB_DD232EBEFAC7]
PSTPIP1-Associated Myeloid-Related Proteinemia Inflammatory (PAMI) Syndrome: A Systematic Review.
Mejbri M., Renella R., Candotti F., Jaques C., Holzinger D., Hofer M., Theodoropoulou K., 2023/08/19. Genes, 14 (8) p. 1655. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4AFB0AA68AA]
 
Insuffisance cardiaque aiguë comme présentation principale d'un syndrome catastrophique des antiphospholipides
Friedrich Bastien P., Burger Raphal, Alberio Lorenzo, Girod Grgoire, Kissling Sbastien, Grandoni Francesco, Graf Guillaume, Ribi Camillo, 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_ADEB2BF23102]
Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine.
Mencarelli L., Moi L., Dewarrat N., Monti M., Alberio L., Ringwald M., Swierdzewska K., Panagiotis A., Ribi C., 2023/08/07. Vaccines, 11 (8) p. 1335. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CE251741A8E]
 
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
Lescoat A., Huang S., Carreira P.E., Siegert E., de Vries-Bouwstra J., Distler JHW, Smith V., Del Galdo F., Anic B., Damjanov N. et al., 2023/08/01. JAMA dermatology, 159 (8) pp. 837-847. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D3F9BC1AB36]
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.
Fallet B., Foglierini M., Porret R., Alcaraz-Serna A., Sauvage C., Jenelten R., Caplanusi T., Gilliet M., Perez L., Fenwick C. et al., 2023/08. The Journal of infection, 87 (2) pp. 111-119. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9DA429039D3E]
Neoadjuvant Immunotherapy: A Promising New Standard of Care.
Boydell E., Sandoval J.L., Michielin O., Obeid M., Addeo A., Friedlaender A., 2023/07/24. International journal of molecular sciences, 24 (14) p. 11849. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EBC57E22479F]
The Statistical Analysis of the Varying Brain.
Chén Oliver Y., Thanh Vũ Duy, Greub Gilbert, Cao Hengyi, He Xingru, Muller Yannick, Petrovas Constantinos, Shou Haochang, Nguyen Viet-Dung, Zhi Bangdong et al., 2023/07/02. IEEE Statistical Signal Processing (SSP). Peer-reviewed.
[URN][DOI][WoS][serval:BIB_C6B3B6AA1F8B]
Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19.
Hocini H., Wiedemann A., Blengio F., Lefebvre C., Cervantes-Gonzalez M., Foucat E., Tisserand P., Surenaud M., Coléon S., Prague M. et al., 2023/07. Journal of clinical immunology, 43 (5) p. 894. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E5F153F4367A]
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.
Hocini H., Wiedemann A., Blengio F., Lefebvre C., Cervantes-Gonzalez M., Foucat E., Tisserand P., Surenaud M., Coléon S., Prague M. et al., 2023/07. Journal of clinical immunology, 43 (5) pp. 882-893. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_30D621CDC238]
A scalable workflow to test “shock and kill” therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo
Procopio Francesco Andrea, Savarino Andrea, Shytaj Iart Luca, 2023/06. STAR Protocols, 4 (2) p. 102253. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2DD4D5126887]
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex.
Vicino A., Cochet S., Pistocchi S., Conrad C., Ribi C., Du Pasquier R., Brouland J.P., Théaudin M., 2023/06. Journal of the peripheral nervous system, 28 (2) pp. 266-268. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A5312D01C4F]
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies.
Godinho R., Noto A., Fenwick C., Stravodimou A., Hugelshofer S., Peters S., Hullin R., Obeid M., 2023/06. Journal for immunotherapy of cancer, 11 (6). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D3B4F544BDF7]
 
Gene Therapy for Inborn Errors of Immunity.
Arlabosse T., Booth C., Candotti F., 2023/06. The journal of allergy and clinical immunology. In practice, 11 (6) pp. 1592-1601. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_74E2CD2A10A2]
 
OP0020 The Cellular Metabolism of Sle Nk Cells is Primarily Altered at the Level of Mitochondrial Homeostasis
Fluder N., Humbel M., Ribi C., Comte D., 2023/06., EULAR 2023 European Congress of Rheumatology, 31 May - 3 June pp. 13.1-13 dans Scientific Abstracts.
[DOI][WoS][serval:BIB_00EC7F457269]
Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study.
Dumusc A., Alromaih F., Perreau M., Hügle T., Zufferey P., Dan D., 2023/06/01. Arthritis research & therapy, 25 (1) p. 91. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DF31B58270DC]
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer.
Liu C., Shatila M., Mathew A., Machado A.P., Thomas A., Zhang H.C., Thomas A.S., Faleck D., Funchain P., Philpott J. et al., 2023/06. Journal of Cancer, 14 (10) pp. 1913-1919. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7A07F987C9FE]
 
Pneumonies communautaires sévères : utilité des corticostéroïdes.
Bart P.A., 2023/05/31. Revue medicale suisse, 19 (829) pp. 1110-1111. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_29599D507B0F]
Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease.
Gatterer C., Beitzke D., Graf S., Lenz M., Sunder-Plassmann G., Mann C., Ponleitner M., Manka R., Fritschi D., Krayenbuehl P.A. et al., 2023/05/19. Life, 13 (5) p. 1213. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_755681B65A74]
Severe combined immunodeficiency: improved survival leading to detection of underlying liver disease.
Vittal A., Abdul Majeed N., Garabedian E., Marko J., Kleiner D.E., Sokolic R., Candotti F., Malech H., Heller T., Koh C., 2023/05/19. BMC gastroenterology, 23 (1) p. 166. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5F4596E72743]
ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification Propensity.
Halfon M., Zhang L., Ehirchiou D., Pandian V.D., Dahdal S., Huynh-Do U., Pasch A., Ribi C., Busso N., 2023/05/18. Genes, 14 (5) p. 1105. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B144EDB59ADF]
Vaccins contre le RSV: nouveaux arrivants – après SARS-CoV-2 – sur la scène des vaccins.
Bart P.A., 2023/05/10. Revue medicale suisse, 19 (826) p. 923. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_44E440056731]
AKT activity orchestrates marginal zone B cell development in mice and humans.
Cox E.M., El-Behi M., Ries S., Vogt J.F., Kohlhaas V., Michna T., Manfroi B., Al-Maarri M., Wanke F., Tirosh B. et al., 2023/04/25. Cell reports, 42 (4) p. 112378. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_07D42F1D9F07]
Association of plasma zinc levels with anti-SARS-CoV-2 IgG and IgA seropositivity in the general population: A case-control study.
Equey A., Berger M.M., Gonseth-Nusslé S., Augsburger M., Rezzi S., Hodgson ACC, Estoppey S., Pantaleo G., Pellaton C., Perrais M. et al., 2023/04/18. Clinical nutrition, 42 (6) pp. 972-986. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BEE6C76A8AC7]
Remodelling family medicine teaching at the University of Lausanne using a modified Delphi method.
Pedrazzini B., Boulet M.C., Héritier F., Bart P.A., Senn N., 2023/04/17. Swiss medical weekly, 153 (4) p. 40064. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6EB84AD82053]
Granulomatose avec polyangéite : quoi de neuf ? [Granulomatosis with polyangiitis: what's new?]
Ringwald M., Chevalley D., Bongard C., Kissling S., Rotman S., Von Garnier C., Ribi C., Comte D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 674-679. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D369BEFFD011]
Hypersensibilité aux venins d’hyménoptères : le point en 2023 [Hymenoptera venom allergy: what's new in 2023]
Belkoniene M., Ringwald M., Leimgruber A., Muller Y.D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 663-667. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_53B0B7C3150B]
La concision est l’âme de l’esprit.
Seebach J.D., Ribi C., 2023/04/05. Revue medicale suisse, 19 (821) pp. 655-656. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_43703F2D61EC]
Maladie des anticorps anti-membrane basale glomérulaire [Anti-glomerular basement membrane disease]
Stevanin M., Kissling S., Daccord C., Rotman S., Comte D., Ribi C., 2023/04/05. Revue medicale suisse, 19 (821) pp. 680-685. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_89863117120D]
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines.
Stehlin F., Tommasini F., Monzambani-Banderet V., Girard C., Yerly D., Ribi C., Muller Y.D., 2023/04. Allergology international, 72 (2) pp. 332-334. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1AE52F9BF9D]
O.18.2 - How different dimensions of medical students’ empathy relate to mental health and burnout: Presenter(s): Alexandre Berney, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland; Sylvie Berney, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland
Carrard Valerie, Schlegel Katja, Gauma Jacques, Bart Pierre-Alexandre, Preisig Martin, Schmid Mast Marianne, Bourquin Céline, 2023/04/01. Patient Education and Counseling. Peer-reviewed.
[URN][serval:BIB_51A34757A3D1]
 
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.
Balakrishna S., Loosli T., Zaheri M., Frischknecht P., Huber M., Kusejko K., Yerly S., Leuzinger K., Perreau M., Ramette A. et al., 2023/03/02. The Journal of antimicrobial chemotherapy, 78 (3) pp. 656-664. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_213147216CE3]
 
Access to gene therapy for rare diseases when commercialization is not fit for purpose.
Fox T., Bueren J., Candotti F., Fischer A., Aiuti A., Lankester A., AGORA Initiative, Booth C., 2023/03. Nature medicine, 29 (3) pp. 518-519. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E19E38D216AF]
Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
Mathias A., Pantazou V., Perriot S., Canales M., Jones S., Oberholster L., Moulin M., Fenwick C., Bernard-Valnet R., Théaudin M. et al., 2023/03. Neurology: Neuroimmunology & Neuroinflammation, 10 (2) pp. e200084. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_53DB58799AAF]
 
Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development.
Scherer S., Oberle S.G., Kanev K., Gerullis A.K., Wu M., de Almeida G.P., Puleston D.J., Baixauli F., Aly L., Greco A. et al., 2023/03. Nature immunology, 24 (3) pp. 501-515. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_37BBC13C5B60]
What Is New in Pulmonary Mucormycosis?
Danion F., Coste A., Le Hyaric C., Melenotte C., Lamoth F., Calandra T., Garcia-Hermoso D., Aimanianda V., Lanternier F., Lortholary O., 2023/02/28. Journal of fungi, 9 (3) p. 307. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FC89D4B5FCED]
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults.
Cohen K.W., Fiore-Gartland A., Walsh S.R., Yusim K., Frahm N., Elizaga M.L., Maenza J., Scott H., Mayer K.H., Goepfert P.A. et al., 2023/02/15. The Journal of clinical investigation, 133 (4) pp. e163338. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4401BE6482F7]
 
Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach.
Labarile M., Loosli T., Zeeb M., Kusejko K., Huber M., Hirsch H.H., Perreau M., Ramette A., Yerly S., Cavassini M. et al., 2023/02/14. The Journal of infectious diseases, 227 (4) pp. 554-564. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AAE8A3C815DF]
Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland.
Duperrex O., Tommasini F., Muller Y.D., 2023/02/01. JAMA network open, 6 (2) pp. e2254298. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4E084F2628B]
 
"Inborn errors of immunity: An expanding horizon through a multitude of biological pathways".
Candotti F., Eigenmann P., 2023/01. Pediatric allergy and immunology, 34 (1) pp. e13908. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1E194F423ED2]
A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells.
Joo V., Petrovas C., de Leval L., Noto A., Obeid M., Fenwick C., Pantaleo G., 2023. Frontiers in immunology, 14 p. 1213375. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_431B1ABF3E8A]
 
Brain Cortical Thickness Predicts Outcomes in Alzheimer’s Disease.
Chén Oliver Y. et al., 2023..
[serval:BIB_088C64508490]
Case report: First-in-human combined low-dose whole-heart irradiation and high-dose stereotactic arrhythmia radioablation for immunosuppressive refractory cardiac sarcoidosis and ventricular tachycardia.
van der Ree M.H., Herrera Siklody C., Le Bloa M., Pascale P., Porretta A.P., Teres C.C., Solana Munoz J., Luca A., Domenichini G., Ozasahin M. et al., 2023. Frontiers in cardiovascular medicine, 10 p. 1213165. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FA14CF085E93]
Differential Production of Midkine and Pleiotrophin by Innate APCs upon Stimulation through Nucleic Acid-Sensing TLRs.
Said E.A., Al-Dughaishi S., Al-Hatmi W., Al-Reesi I., Al-Balushi M.S., Al-Bimani A., Al-Busaidi J.Z., Al-Riyami M., Al-Khabori M., Al-Kindi S. et al., 2023. Journal of immunology research, 2023 p. 7944102. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_708E1F22F737]
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study.
de Rougemont O., Deng Y., Frischknecht L., Wehmeier C., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2023. Frontiers in immunology, 14 p. 1104371. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9C3FDBD902B3]
Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation.
Ballou C., Barton F., Payne E.H., Berney T., Villard J., Meier RPH, Baidal D., Alejandro R., Robien M., Eggerman T.L. et al., 2023. Frontiers in immunology, 14 p. 1110544. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_04D10C842266]
Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein.
Perdiguero B., Hauser A., Gómez C.E., Peterhoff D., Sideris E., Sorzano CÓS, Wilmschen S., Schaber M., Stengel L., Asbach B. et al., 2023. Frontiers in immunology, 14 p. 1270908. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D789F3FAEA8A]
 
Regulatory T cell homeostasis: Requisite signals and implications for clinical development of biologics.
Skartsis N., Muller Y.D., Ferreira LMR, 2023/01. Clinical immunology, 246 p. 109201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_460C30B477F0]
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
Stalder G., Suffiotti M., Segot A., Noto A., Pantaleo G., Spertini O., Obeid M., 2023/01/01. Haematologica, 108 (1) pp. 234-239. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5551F9C73188]
SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection.
Jacot D., von Rotz U., Pellaton C., Blondet F., Aebischer O., Perreau M., De Rham M., Pantaleo G., Marchetti O., Greub G., 2023. Microbes and infection, 25 (1-2) p. 105077. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35EA6DCB0511]
2022
A differential process mining analysis of COVID-19 management for cancer patients.
Cuendet M.A., Gatta R., Wicky A., Gerard C.L., Dalla-Vale M., Tavazzi E., Michielin G., Delyon J., Ferahta N., Cesbron J. et al., 2022/12/07. Frontiers in oncology, 12 p. 1043675. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_98AD494947E5]
 
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Haanen J., Obeid M., Spain L., Carbonnel F., Wang Y., Robert C., Lyon A.R., Wick W., Kostine M., Peters S. et al., 2022/12. Annals of oncology, 33 (12) pp. 1217-1238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F3804F73BCD6]
 
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.
Bettiol A., Urban M.L., Bello F., Fiori D., Mattioli I., Lopalco G., Iannone F., Egan A., Dagna L., Caminati M. et al., 2022/12. Annals of the rheumatic diseases, 81 (12) pp. 1769-1772. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3882E44472F2]
CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses.
Noto A., Joo V., Mancarella A., Suffiotti M., Pellaton C., Fenwick C., Perreau M., Pantaleo G., 2022/11/28. Viruses, 14 (12) p. 2665. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1C95F51CD2B0]
 
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Zanatta E., Huscher D., Ortolan A., Avouac J., Airò P., Balbir-Gurman A., Siegert E., Matucci Cerinic M., Cozzi F., Riemekasten G. et al., 2022/11/28. Rheumatology, 61 (12) pp. 4786-4796. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C34847ADF34]
Host Molecule Incorporation into HIV Virions, Potential Influences in HIV Pathogenesis.
Munoz O., Banga R., Perreau M., 2022/11/14. Viruses, 14 (11). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E603E7404562]
 
Rapid onset of chronic urticaria after Moderna COVID-19 booster vaccine
Olivier Duperrex, Francesco Tommasini, Yannick Muller, 2022/11/04..
[DOI][serval:BIB_E54D8CF6479E]
 
Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines.
Pescosolido E., Muller Y.D., Sabaté-Brescó M., Ferrer M., Yerly D., Caubet J.C., Lantin J.P., Ribi C., Bergmann M.M., 2022/11. Clinical and experimental allergy, 52 (11) pp. 1343-1346. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75DE4F933D73]
Inhibiteurs des Janus kinases : nouvelles perspectives pour la médecine de précision ? [Janus kinase inhibitors : new perspectives for precision medicine ?]
Tachet J., Dumusc A., Conrad C., Grandoni F., Chalandon Y., Ribi C., Buclin T., Girardin F., 2022/10/19. Revue medicale suisse, 18 (800) pp. 1979-1983. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0D12F79D0C49]
 
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Hashem H., Bucciol G., Ozen S., Unal S., Bozkaya I.O., Akarsu N., Taskinen M., Koskenvuo M., Saarela J., Dimitrova D. et al., 2022/10..
[DOI][WoS][Pmid][serval:BIB_158647440B8D]
COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions.
Schrijver I.T., Théroude C., Antonakos N., Regina J., Le Roy D., Bart P.A., Chiche J.D., Perreau M., Pantaleo G., Calandra T. et al., 2022/10. European journal of immunology, 52 (10) pp. 1676-1679. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE51282F926C]
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
Coukos A., Vionnet J., Obeid M., Bouchaab H., Peters S., Latifyan S., Wicky A., Michielin O., Chtioui H., Moradpour D. et al., 2022/10. Journal for immunotherapy of cancer, 10 (10) pp. e005635. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F836C2B098EA]
 
A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study.
Chaudron S.E., Leemann C., Kusejko K., Nguyen H., Tschumi N., Marzel A., Huber M., Böni J., Perreau M., Klimkait T. et al., 2022/09/28. The Journal of infectious diseases, 226 (7) pp. 1256-1266. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F747BBEF0F8F]
Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditions.
Perriot S., Canales M., Mathias A., Du Pasquier R., 2022/09/16. STAR protocols, 3 (3) p. 101620. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8C8118CBC867]
Different classes of genomic inserts contribute to human antibody diversity.
Lebedin M., Foglierini M., Khorkova S., Vázquez García C., Ratswohl C., Davydov A.N., Turchaninova M.A., Daubenberger C., Chudakov D.M., Lanzavecchia A. et al., 2022/09/06. Proceedings of the National Academy of Sciences of the United States of America, 119 (36) pp. e2205470119. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7CD7BE178493]
Antibodies to combat viral infections: development strategies and progress.
Pantaleo G., Correia B., Fenwick C., Joo V.S., Perez L., 2022/09. Nature reviews. Drug discovery, 21 (9) pp. 676-696. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09F440C68729]
 
Editorial comment on "Inborn errors of immunity associated with defects of thymic development".
Beken B., Castagnoli R., Candotti F., 2022/09. Pediatric allergy and immunology, 33 (9) pp. e13847. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEF54F454139]
Long-term outcomes in corticosteroid-refractory Graves' orbitopathy treated with tocilizumab.
Moi L., Hamedani M., Ribi C., 2022/09. Clinical endocrinology, 97 (3) pp. 363-370. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EAD5932101A4]
Magnitude and associated factors of latent tuberculosis infection due to Mycobacterium tuberculosis complex among high-risk groups in urban Bobo-Dioulasso, Burkina Faso.
Djibougou D.A., Mensah G.I., Sagna T., Sawadogo L.T., Ouedraogo A.K., Kabore A., Hien H., Meda C.Z., Combary A., Belem A.M. et al., 2022/09. IJID regions, 4 pp. 1-9. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_66E3C334DF46]
 
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys.
Fenwick C., Turelli P., Ni D., Perez L., Lau K., Herate C., Marlin R., Lana E., Pellaton C., Raclot C. et al., 2022/09. Nature microbiology, 7 (9) pp. 1376-1389. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_539E1A543541]
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort.
Menges D., Zens K.D., Ballouz T., Caduff N., Llanas-Cornejo D., Aschmann H.E., Domenghino A., Pellaton C., Perreau M., Fenwick C. et al., 2022/08/18. Nature communications, 13 (1) p. 4855. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F6D33AB61943]
A Phylogeny-aware GWAS Framework to Correct for Heritable Pathogen Effects on Infectious Disease Traits.
Nadeau S., Thorball C.W., Kouyos R., Günthard H.F., Böni J., Yerly S., Perreau M., Klimkait T., Rauch A., Hirsch H.H. et al., 2022/08/03. Molecular biology and evolution, 39 (8) pp. msac163. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C0A2EB45D9AE]
Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022.
Amati R., Frei A., Kaufmann M., Sabatini S., Pellaton C., Fehr J., Albanese E., Puhan M.A., Corona Immunitas Research Group, 2022/08. Euro surveillance, 27 (31). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6DDFE21CA95A]
 
SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
Jacot D., von Rotz U., Blondet F., Aebischer O., Matthieu P., De Rham M., Pantaleo G., Marchetti O., Greub G., 2022/08. Journal of medical microbiology, 71 (8). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E339D4530BF]
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics.
Kusejko K., Tschumi N., Chaudron S.E., Nguyen H., Battegay M., Bernasconi E., Böni J., Huber M., Calmy A., Cavassini M. et al., 2022/08/01. Journal of acquired immune deficiency syndromes, 90 (4) pp. e4-e12. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6FD8C532081B]
 
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
Nguyen H., Hampel B., Nuñez D.G., Battegay M., Hachfeld A., Bernasconi E., Calmy A., Cavassini M., Vernazza P., Fellay J. et al., 2022/07/06. Clinical infectious diseases, 74 (12) p. 2266. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D8CAA9F6BAD]
Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells.
Munoz O., Banga R., Schelling R., Procopio F.A., Mastrangelo A., Nortier P., Ohmiti K., Daraspe J., Cavassini M., Fenwick C. et al., 2022/07. PLoS pathogens, 18 (7) pp. e1010673. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BEB839579791]
 
Common Variable Immunodeficiency in a Carrier of the ADA2 R169Q Variant: Coincidence or Causality?
Moi L., Schnider C., Riccio O., Hershfield M.S., Candotti F., 2022/07. Journal of clinical immunology, 42 (5) pp. 959-961. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CB464CB7181B]
Measurement of circulating CD21-CD27- B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers.
Horisberger A., Humbel M., Fluder N., Bellanger F., Fenwick C., Ribi C., Comte D., 2022/06/02. Scientific reports, 12 (1) p. 9189. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_79225BAA39D6]
 
Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity.
Chasset F., Mathian A., Dorgham K., Ribi C., Trendelenburg M., Huynh-Do U., Roux-Lombard P., Courvoisier D.S., Amoura Z., Gorochov G. et al., 2022/06. Annals of the rheumatic diseases, 81 (6) pp. 901-903. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F017A3490498]
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient.
Girardin F.R., Tzankov A., Pantaleo G., Livio F., Greub G., 2022/05/23. Swiss medical weekly, 152 pp. w30188. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_378A2D414165]
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
Kritikos A., Gabellon S., Pagani J.L., Monti M., Bochud P.Y., Manuel O., Coste A., Greub G., Perreau M., Pantaleo G. et al., 2022/05/18. Viruses, 14 (5) p. 1089. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7AA364497D07]
 
Behçet's-like adverse event or inaugural Behçet's disease after SARS-CoV-2 mRNA-1273 vaccination?
Tagini F., Carrel L., Fallet B., Gachoud D., Ribi C., Monti M., 2022/05/05. Rheumatology, 61 (5) pp. e112-e113. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E6FC4FFA465]
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
Obeid M., Suffiotti M., Pellaton C., Bouchaab H., Cairoli A., Salvadé V., Stevenel C., Hottinger R., Pythoud C., Coutechier L. et al., 2022/05/01. JAMA oncology, 8 (5) pp. e220446. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8956034C5615]
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
Lazor-Blanchet C., Zygoura P., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Grandbastien B., Fenwick C., Pantaleo G. et al., 2022/05. The Journal of infection, 84 (5) pp. 722-746. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB5408AF350D]
 
Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
Nguyen H., Hampel B., Garcia Nuñez D., Battegay M., Hachfeld A., Bernasconi E., Calmy A., Cavassini M., Vernazza P., Fellay J. et al., 2022/04/28. Clinical infectious diseases, 74 (8) pp. 1468-1475. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_966C936A2B27]
T cell receptor and IL-2 signaling strength control memory CD8<sup>+</sup> T cell functional fitness via chromatin remodeling.
Chin S.S., Guillen E., Chorro L., Achar S., Ng K., Oberle S., Alfei F., Zehn D., Altan-Bonnet G., Delahaye F. et al., 2022/04/26. Nature communications, 13 (1) p. 2240. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F1F88D878BE]
Déficit en adénosine désaminase 2 : une maladie aux présentations multiples [Adenosine deaminase 2 deficiency: a disease with multiple presentations]
Caratsch L., Schnider C., Moi L., Theodoropoulou K., Candotti F., Hofer M., 2022/04/06. Revue medicale suisse, 18 (776) pp. 669-673. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D3726C7A7818]
Maladies causées par Anisakis simplex chez l’humain [Human diseases caused by Anisakis simplex]
Ringwald M., Muller Y.D., Ribi C., 2022/04/06. Revue medicale suisse, 18 (776) pp. 634-638.
[URN][DOI][Pmid][serval:BIB_C100DD2F9489]
Réactions d’hypersensibilité au fer intraveineux : le point de vue de l’allergologue [Hypersensitivity reactions to intravenous iron: an allergist' perspective]
Moi L., Stehlin F., Desseauve D., Ribi C., Muller Y.D., 2022/04/06. Revue medicale suisse, 18 (776) pp. 639-645. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_549B88D4BEB5]
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
Herderschee J., Heinonen T., Fenwick C., Schrijver I.T., Ohmiti K., Moradpour D., Cavassini M., Pantaleo G., Roger T., Calandra T. et al., 2022/04. Clinical microbiology and infection, 28 (4) pp. 611.e1-611.e7. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_300AF1BADC64]
 
Procalcitonina es superior a recuento linfocitario, índice neutrófilo/linfocito y proteína C reactiva para la predicción de mortalidad a 30 días de pacientes con COVID-19 en el servicio de urgencias = Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein level.
López-Ayala P., Alcaraz-Serna A., Valls Carbó A., Cuadrado Cenzual M.Á., Torrejón Martínez M.J., López Picado A., Martínez Valero C., Miranda J.D., Díaz Del Arco C., Cozar López G. et al., 2022/04. Emergencias, 34 (2) pp. 119-127. Peer-reviewed.
[WoS][Pmid][serval:BIB_74504AC9E2AD]
 
Signaling networks in B cell development and related therapeutic strategies.
Ren A., Sun J., Yin W., Westerberg L.S., Miller H., Lee P., Candotti F., Guan F., Lei J., Gong Q. et al., 2022/04. Journal of leukocyte biology, 111 (4) pp. 877-891. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B8683F218609]
Structural basis for HCMV Pentamer receptor recognition and antibody neutralization.
Kschonsak M., Johnson M.C., Schelling R., Green E.M., Rougé L., Ho H., Patel N., Kilic C., Kraft E., Arthur C.P. et al., 2022/03/11. Science advances, 8 (10) pp. eabm2536. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9AD2F453F4AF]
Critical role of WASp in germinal center tolerance through regulation of B cell apoptosis and diversification.
Descatoire M., Fritzen R., Rotman S., Kuntzelman G., Leber X.C., Droz-Georget S., Thrasher A.J., Traggiai E., Candotti F., 2022/03/08. Cell reports, 38 (10) p. 110474. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_114B7364DECA]
Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors.
Moret E., Ambresin A., Gianniou C., Bijon J., Besse-Hayat C., Bogiatzi S., Hohl D., Spertini F., Mantel I., 2022/03. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 260 (3) pp. 1005-1014. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C16845CB364E]
 
SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties
Fenwick Craig, Turelli Priscilla, Ni Dongchun, Perez Laurent, Lau Kelvin, Lana Erica, Pellaton Céline, Raclot Charlène, Esteves-Leuenberger Line, Campos Jérémy et al., 2022/03..
[DOI][serval:BIB_938CCD54F9CA]
 
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).
Scherrer A.U., Traytel A., Braun D.L., Calmy A., Battegay M., Cavassini M., Furrer H., Schmid P., Bernasconi E., Stoeckle M. et al., 2022/02/18. International journal of epidemiology, 51 (1) pp. 33-34j. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CAE07421BB63]
Detecting Selection in the HIV-1 Genome during Sexual Transmission Events.
Seifert D., Joos B., Braun D.L., Oberle C.S., Schenkel C.D., Kuster H., Grube C., Böni J., Yerly S., Aubert V. et al., 2022/02/16. Viruses, 14 (2) p. 406. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0B43AB7DD662]
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.
Bettiol A., Urban M.L., Dagna L., Cottin V., Franceschini F., Del Giacco S., Schiavon F., Neumann T., Lopalco G., Novikov P. et al., 2022/02. Arthritis & rheumatology, 74 (2) pp. 295-306. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_01372D0A9355]
Allergologie-immunologie - Maladies autoimmunes complexes : quand les glucocorticoïdes ne suffisent plus [Difficult to treat auto-immune diseases : when glucocorticoids are not enough]
Dereme J., Belkoniene M., Ribi C., 2022/01/19. Revue medicale suisse, 18 (764-5) pp. 15-17. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AECB3687D942]
 
Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study.
Duran Ramirez J.J., Ballouz T., Nguyen H., Kusejko K., Chaudron S.E., Huber M., Hirsch H.H., Perreau M., Ramette A., Yerly S. et al., 2022/01/18. The Journal of infectious diseases, 225 (2) pp. 306-316. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A7E78283DB80]
Has the profile of heart transplantation recipients changed within the last three decades?
Anouck Z., Tozzi P., Regamey J., Abdurashidova T., Meyer P., Lefol K., Pascual M., Yerly P., Aubert V., Aur S. et al., 2022/01/17. Swiss medical weekly, 152 pp. w30108. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_31EADDEE19EC]
Sarcoidosis - a multisystem disease.
Franzen D.P., Brutsche M., Nilsson J., Böni C., Daccord C., Distler O., Elsener D., Funke-Chambour M., Gruner C., Hayward-Könnecke H. et al., 2022/01/03. Swiss medical weekly, 152 pp. w30049. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BE7643C6051D]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University